Evidence map›Paper›PMID 36358131›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Identification and Characterization of Genes Related to Ampicillin Antibiotic Resistance in

Binan Geng, Xingyu Huang, Yalun Wu, Qiaoning He, Shihui Yang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Pangenome analysis ofAntimicrobial agents and chemotherapy · 2026
    Article
  2. Review
  3. Article
  4. Synthetic Biology Facilitates Antimicrobials Discovery.Antibiotics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Binan GengState Key Laboratory of Biocatalysis and Enzyme Engineering, Environmental Microbial Technology Center of Hubei Province, School of Life Sciences, Hubei University, Wuhan 430062, China.
Xingyu HuangState Key Laboratory of Biocatalysis and Enzyme Engineering, Environmental Microbial Technology Center of Hubei Province, School of Life Sciences, Hubei University, Wuhan 430062, China.
Yalun WuState Key Laboratory of Biocatalysis and Enzyme Engineering, Environmental Microbial Technology Center of Hubei Province, School of Life Sciences, Hubei University, Wuhan 430062, China.
Qiaoning HeState Key Laboratory of Biocatalysis and Enzyme Engineering, Environmental Microbial Technology Center of Hubei Province, School of Life Sciences, Hubei University, Wuhan 430062, China.
Shihui YangState Key Laboratory of Biocatalysis and Enzyme Engineering, Environmental Microbial Technology Center of Hubei Province, School of Life Sciences, Hubei University, Wuhan 430062, China.ORCID 0000-0002-9394-9148
Hubei University · CN

Funding

National Key Research and Development Program of China, National Natural Science Foundation of China,Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang Province,the Innovation Base for Introducing Talents of Discipline of Hubei Prov 2018YFA0900300; 21978071 and U1932141; 2018R01014; 2019BJH021
6 · The paper itself

Abstract

Antibiotics can inhibit or kill microorganisms, while microorganisms have evolved antibiotic resistance strategies to survive antibiotics.

Indexed as

ampicillinantibiotic resistanceCRISPR−Cas12agenome editingresistance selection markersZymomonas mobilis

Identifiers

PMID36358131
PMCPMC9686808
OpenAlexW4307240317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.